Global Clinical Nutrition Products Industry

  • October 2013
  • -
  • Global Industry Analysts
  • -
  • 359 pages

This report analyzes the worldwide markets for Clinical Nutrition Products in US$ Million by the following Product Segments: Enteral Nutrition, Infant Nutrition, and Parenteral Nutrition.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East/Africa, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

The report profiles 68 companies including many key and niche players such as -
Abbott Laboratories, Inc.
Abbott Nutrition
Ajinomoto Co., Inc.
American HomePatient, Inc.
Baxter International, Inc.
B. Braun Melsungen AG
Claris Lifesciences Ltd.
Groupe Danone
Nutricia North America

Table Of Contents




I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-2
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
1. Enteral Nutrition I-3
2. Infant Nutrition I-4
3. Parenteral Nutrition I-4


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
A Bird’s Eye View of the Clinical Nutrition Products Market II-1
Emerging Markets: The New Hotspots for Growth II-2
Infant Nutrition: The Largest and Fastest Growing Category II-2
Impact of Healthcare Budget Cuts: A Review II-3
Table 1: Healthcare Spending as a Percentage of GDP in Select
Countries (includes corresponding Graph/Chart) II-4
Competitive Landscape II-5
Table 2: Leading Players in the Global Clinical Nutrition
Market (2012): Percentage Breakdown of Value Sales for Abbott
Laboratories, Nestle, Fresenius Kabi, Danone, B. Braun,
Baxter International and Others (includes corresponding
Graph/Chart) II-6
Enteral Nutrition Market II-7
Table 3: Leading Players in the Global Enteral Nutrition
Market (2012): Percentage Breakdown of Value Sales for
Abbott, Nestle, Danone, Fresenius and Others (includes
corresponding Graph/Chart) II-7
Infant Nutrition Market II-7
Table 4: Leading Players in the Global Infant Nutrition
Market (2012): Percentage Share Breakdown of Value Sales for
Nestle S.A, Danone, Mead Johnson Nutrition, Abbott, Heinz and
Others (includes corresponding Graph/Chart) II-7
Global Parenteral Nutrition Market II-8
Table 5: Leading Players in the Global Parenteral Nutrition
Market (2012): Percentage Share Breakdown of Value Sales for
Baxter International, Fresenius Kabi, B.Braun, Hospira and
Others (includes corresponding Graph/Chart) II-8

2. MARKET DRIVERS, TRENDS and ISSUES II-9
Ageing Population: A Strong Growth Driver II-9
Table 6: Elderly Population (65+ Years) as a Percentage of
the Total Population: 2000 and 2025 (includes corresponding
Graph/Chart) II-10

Table 7: Global Population Statistics for the 65+ Age Group
(2012) (includes corresponding Graph/Chart) II-11
Rising Incidence of Chronic Diseases to Kindle Market Growth
in Clinical Nutrition Products Market II-12
World Cancer Statistics: Incidence and Mortality Data II-12
Table 8: World Cancer Incidence by Geographic Region and
Gender (2012): Number of New Cancer Cases Reported (in
Thousands) for Asia-Oceania, Europe, North America, Latin
America and the Caribbean, and Africa (includes corresponding
Graph/Chart) II-13

Table 9: World Cancer Mortality by Geographic Region and
Gender (2012): Number of Cancer-Related Deaths (in
Thousands) for Asia-Oceania, Europe, North America, Latin
America and the Caribbean, and Africa (includes corresponding
Graph/Chart) II-14

Table 10: New Cancer Cases in the World by Affected Site
(2012) (In Thousands) (includes corresponding Graph/Chart) II-15

Table 11: Global Incidence of Common Cancers in Men (2012):
Number of New Cases Reported in Thousands for Lung and
Bronchus, Prostate, Colorectal and Liver Cancers (includes
corresponding Graph/Chart) II-16

Table 12: Global Incidence of Common Cancers in Women
(2012): Number of New Cases Reported in Thousands for
Breast, Colorectal, Lung and Bronchus and Liver Cancers
(includes corresponding Graph/Chart) II-16

Table 13: Global Cancer Mortality in Men for Select Cancers
(2012): Number of Deaths in Thousands for Lung and Bronchus,
Liver, Colorectal and Prostate Cancers (includes
corresponding Graph/Chart) II-17

Table 14: Global Cancer Mortality in Women for Select
Cancers (2012): Number of Deaths in Thousands for Breast,
Lung and Bronchus, Colorectal and Liver (includes
corresponding Graph/Chart) II-17
Cancer Prone Sites based on Age II-17
Diabetes Mellitus: Another Key Chronic Disease II-17
Table 15: Worldwide Prevalence of Diabetes Mellitus by
Region: 2012 and 2030 (includes corresponding Graph/Chart) II-18

Table 16: Prevalence of Diabetes Mellitus in Europe (2012 and
2030): Breakdown by Country and Age Group (in 000 People and %) II-19

Table 17: Prevalence of Diabetes Mellitus in South East Asia
(2012 and 2030): Breakdown by Country and Age Group (in ‘000
People and %) II-20

Table 18: Prevalence of Diabetes Mellitus in Western Asia,
Pacific Regions (2012 and 2030): Breakdown by Country and Age
Group (in 000 People and %) II-20

Table 19: Prevalence of Diabetes Mellitus in South and Central
America (2012 and 2030): Breakdown by Country and Age Group
(in 000 People and %) II-21

Table 20: Prevalence of Diabetes Mellitus in Africa (2012 and
2030): Breakdown by Country and Age Group (in 000 People and %) II-22

Table 21: Prevalence of Diabetes Mellitus in Middle East and
North Africa (2012 and 2030): Breakdown by Country and Age
Group (in 000 People and %) II-23
Parental Nutrition Therapy Indicated for Diabetes Patients
with Non-functional Gastrointestinal Tract II-23
Global HIV Statistics II-24
Table 22: Global Summary of the AIDS Epidemic in 2011
(includes corresponding Graph/Chart) II-24
Some Significant HIV Statistics by Region (2011) II-24
Clinical Nutrition Therapies in Treating Malnutrition Offers
Significant Growth Opportunities II-25
Non-volitional Nutritional Support Therapy - Vital for
Combating Malnutrition during Hospitalization II-26
Trend towards Home Care to Boost Demand for Clinical Nutrition
Products II-26
Changing Health and Social Care Factors Favor Home Enteral
Feeding II-28
Rising Number of Premature Births Augurs Well for Clinical
Nutrition Products Market II-28
Preterm Birth Statistics from WHO II-29
Table 23: Percentage of Preterm Births by Region: 2012
(includes corresponding Graph/Chart) II-30

Table 24: Top Ten Countries with the Highest Number of
Preterm Births (2012) (includes corresponding Graph/Chart) II-31

Table 25: Top Ten Countries with the Highest Rates of
Preterm Births (per 100 Live Births): 2012 (includes
corresponding Graph/Chart) II-32
Demand for Personalized Medicine to Bode Well for Clinical
Nutrition Products Market II-32
Product Innovations Blur the Lines between Medicine and Foods II-33
Surging Demand for Omega-3 Fatty Acids-Fortified Clinical
Nutrition Products II-34
Technology Advances in Enteral Feeding Devices: Favorable
Prospects for Enteral Nutrition Market II-34
Rising Number of Pediatric Crohn's Disease Patients Fuels
Enteral Nutrition Market II-35
Pre-mixed IV Solutions: A Step towards Safer Medication Practices II-36
Growing Demand for Low-Cost Solutions for Parenteral Nutrition II-36
Rising Preference for Multi-Chamber Bags to Lower Cost of
Parenteral Nutrition Therapy II-37
Increasing Popularity of Intravenous Vitamin C for Cancer
Treatment II-37
Infection Control: A Prime Concern in Parenteral Nutrition II-37
Complacency of Hospitals and Worker/Patient Safety: A Key Issue II-38
Favorable Clinical Findings Strengthens Market Prospects for
Enteral Nutrition II-38
Rising Preference for Enteral Nutrition - A Threat to
Parenteral Nutrition Market II-39
Advantages and Disadvantages of Enteral Nutrition over
Parenteral Nutrition II-40
Major Challenges Confronting Medical Nutrition Products’
Marketers II-40
Safety and Nutrition of Infant Nutrition Products Tops
Priority Charts for Consumers II-41
Impact of Demographic and Socio-cultural Factors on Infant
Nutrition Market II-41
Barriers to Widespread Adoption of Clinical Nutrition Products II-42
Reasons for Not Prescribing Clinical Nutrition Products II-42

3. PRODUCT OVERVIEW II-43
Clinical Nutrition II-43
Advantages of Clinical Nutrition II-43
Clinical Nutrition Products II-44
Infant Nutrition II-44
Important Characteristics of Infant Nutrition Formulas II-45
Table 26: Nutrient Specifications for Infant Formulas (per
100kcal) II-45
List of Infant Nutrition Products II-46
Human Milk Oligosaccharides II-47
Prebiotics in Infant Nutrition II-47
DHA and ARA II-48
Nutrition Products for Preterm Infants II-48
Premature Infant Formula II-48
Transitional Formulas II-49
Human Milk Fortifiers II-49
Metabolic Infant Formulas II-49
Follow-up or Follow-on Formulas II-49
Enteral Administration of Infant Formulas in Neonatal
Intensive Care and General Healthcare Settings II-49
Nipple Feeding II-49
Tube Feeding II-50
Enteral Nutrition or Tube Feeding II-50
Table 27: Daily Electrolyte Requirements for Enteral
Nutrition II-51

Table 28: Daily Trace Element Requirement for Enteral
Nutrition II-51

Table 29: Daily Vitamin Requirements for Enteral Nutrition II-52

Table 30: Daily Trace Element Requirements Enteral Nutrition
in Infants II-52

Table 31: Daily Vitamin Requirements for Enteral Nutrition
in Infants II-52
Enteral Nutrition by Age II-53
Enteral Nutrition for Patients aged 21 and older II-53
Enteral Nutrition for Patients Below 21 Years II-53
Various Types of Enteral Feeding or Tube Feeding II-53
What Constitutes Enteral Nutrition Diets? II-54
Home-Made Diets II-54
Commercial Enteral Formulas II-54
Elemental Formulas II-54
Oligomeric Formulas II-55
Polymeric Formulas II-55
Special Formulas II-55
Pulmonary Formulas II-55
Liver Formulas II-56
Renal Formulas II-56
Diabetes Formulas II-56
Gastrointestinal Dysfunction Formulas II-56
Immuno-modulatory Formulas II-57
Enteral Nutrition in Patients with Acute Renal Failure (ARF) II-57
Table 32: Nutritional Requirements in Patients with ARF II-57
Enteral Nutrition in Conservatively Treated Patients with
Chronic Renal Failure (CRF) II-57
Table 33: Recommendations for Protein Supply in Adult CRF
Patients (in g/kgBW/day) II-58

Table 34: Mineral Requirements for Patients with CRF II-58
Enteral Nutrition in Haemodialysis Patients II-58
Enteral Nutrition in Chronic Ambulatory Peritoneal Dialysis
(CAPD) Patients II-58
Table 35: Recommendations for Protein and Energy Supply in
Adult Patients on Routine Hemodialysis and CAPD II-59

Table 36: Mineral Requirements of Patients on Haemodialysis
and Chronic Ambulatory Peritoneal Dialysis II-59
Complications of Enteral Feeding II-59
Complications Associated with Enteral Tube Feeding II-60
Parenteral Nutrition II-62
Sources of Parenteral Solutions II-63
Routes of Administration II-63
Types of Parenteral Nutrition Solutions II-64
Total Parenteral Nutrition (TPN) II-64
Table 37: Daily Requirements for Total Parenteral
Nutrition (TPN) in Adults II-64
Table 38: Daily Recommended Parenteral Nutritional Intakes
for Newborns II-65
TPN Formulation II-66
Partial Parenteral Nutrition (PPN) II-66
Home Parenteral Nutrition II-66
Parenteral Nutrition Formulations II-66
Standard Solutions II-66
Three-in-One Standard Bags II-67
Two-in-one Standard Bags II-67
Individual Solutions II-67
Non-Standard Solutions II-67
Classification of Parenteral Nutrition by Type of Nutrients II-67
Amino Acids II-67
Carbohydrates II-68
Lipids II-68
Minerals and Electrolytes II-68
Table 39: Daily Electrolyte Requirements for Parenteral
Nutrition II-69
Micronutrients II-69
Vitamins II-69
Table 40: Daily Vitamin Requirements for Parenteral
Nutrition II-70
Trace Elements II-71
Table 41: Daily Trace Element Requirement for Parenteral
Nutrition II-71
Large and Small Volume Parenteral Solutions II-71
Large Volume Parenteral (LVP) Solutions II-71
Small Volume Parenteral (SVP) Solutions II-72
IV Fat Emulsions - Enabling Maintenance of Bodyweight II-72

4. PRODUCT INNOVATIONS/INTRODUCTIONS II-73
Ingredion Europe Introduces UNI-PURE IMF 2332 and UNI-PURE IMF
8561 Infant Nutrition Products II-73
Fonterra China to Launch Self-Branded Infant Formula in China II-73
FDA Clears Fresenius Kabi for Emergency Import of
Injectionable TPN Drugs II-73
Marck Biosciences Receives MCC Approval for Pharma Products II-73
Restore Health Pharmacy Launches High Quality Nutritional
Supplement II-74
Inergetics Introduces Surgex Ready to Drink Nutritional Beverage II-74
Arla Foods Ingredients Introduces Revolutionary Whey Protein II-74
Nestle Health Science Rolls Out SpikeRight® PLUS for Enteral
Safety II-74
Claris Receives USFDA Approval for Marketing Products in the US II-75
Baxter International Launches NUMETA Triple-Chamber IV
Nutrition System II-75
Science Based Health Introduces MacularProtect Omega 3
Companion and MacularProtect Complete Nutritional
Formulations II-75
Pfizer Launches GOLD Range of Nutrition Products for Children II-76
Nestle Lanka Rolls Out NeslacExcella 1+ Infant Milk Formula II-76
Nestle Introduces BabyNes Nutrition System for Toddlers and
Infants II-76
Baxter Launches OLIMEL Emulsion as Canada's First Triple-
Chamber Bag for Parenteral Nutrition II-77
B. Braun Rolls Out NuTRIflex® Omega II-77
PBM Products Introduces Bright Beginnings® NeoCare™ II-78
Fresenius Kabi Launches SmofKaviben II-78
Nutricia Introduces Neocate Nutra II-78
Wimm-Bill-Dann Offers life’sDHA and life’sARA™- Intregrated
Infant Formula II-78
Nestle Launches Infant Nutrition Milk Powder in China II-79
Abbott Introduces Similac Advance EarlyShield™ and Similac®
SimplePacâ„¢ II-79

5. RECENT INDUSTRY ACTIVITY II-80
Nestle Health Science Purchases Pamlab II-80
Danone Takes Over Stake in Happy Family II-80
Aspen Acquires IP Rights in Infant Nutritional Businesses of
Nestle II-80
Danone Completes Acquisition of Wockhardt’s Nutrition Business II-81
Satori Capital Acquires Longhorn Health Solutions II-81
Abbott Nutrition Discontinues Enteral Device Business in the
US and Puerto Rico II-81
Danone Recalls Infant-Formula Products in Asia II-81
Hospira Recalls IV Electrolyte Solution II-82
Depol Sp. z o.o. Hurtownia Farmaceutyczna Secures Contract
from Samodzielny Publiczny Szpital Kliniczny II-82
Nestle Acquires Pfizer Nutrition II-82
Aperture Health Takes Over Triad Therapeutics II-82
Nestle Health Science Acquires Stake in Accera II-82
B Braun Acquires Nutrichem II-83
Mead Johnson Nutrition Enters into Joint Venture with Sancor II-83
Abbott Plans Collaboration with Syngene for Nutrition RandD Unit II-83
AarhusKarlshamn Expands Capacity to Produce InFatâ„¢ II-84
Abbot Inaugurates Nutrition Production Facility in Ohio II-84
BioGaia Enters into a Collaboration Agreement with Nestle II-84
Claris Lifesciences Enters into JV with Otsuka Pharma and
Mitsui for Indian Market II-85
Ajinomoto, USAID and JICA Agency Ink MoU II-85
B. Braun Establishes Pharmaceutical Plant in the US II-85
Evolva Acquires Abunda Nutrition II-86
Medical Australia and Pharmatel Frensius Kabi Ink OEM
Partnership Agreement II-86
Consorci de Salut i Atencio Social de Catalunya Bags Supply
Contract from B. Braun Medical II-86
Fresenius KABI Italia Obtains Supply Contract from ESTAV Sud II-86
Baxter Secures Contract from ASL Milano 1 II-87
FrieslandCampina Plans Capacity Expansion II-87
Nestle HealthCare Establishes Manufacturing Unit to Produce
Nutrition Products and Infant Formulae II-87
Fresenius Kabi and Nutricia Belgique Obtain Contract from CHR
De La Citadelle II-87
Fresenius Kabi Establishes Manufacturing Plant in Vietnam II-88
Grifols to Set Up Form-Fill-Seal Production Lines for
Parenteral Solutions II-88
Baxter International Signs Distribution Agreement with Hanmi
Pharmaceutical II-88
Hospira Enters into Agreements with Novation II-88
Pfizer Takes Over Wyeth II-89
Bristol-Myers Squibb Divests Stake in Mead Johnson Nutrition II-89
Martek Biosciences and Ragasa Ink Agreement II-89
Lactalis Nutrition Sante Signs Agreement with Martek Biosciences II-89
Milk Powder Solutions Signs Agreement with Martek Biosciences II-89
Beech Nut and Abbott Enter into Collaboration II-90
Grupo Ricap Inks Agreement with Martek Biosciences II-90
Abbott Nutrition Opens New Production Unit II-90
Alticor and Metagenics Enter into Joint Venture II-90
Hain Celestial and Hutchison China Meditech Enter into Joint
Venture II-90
Hangzhou Minsheng Pharmaceutical and Choongwae Holdings Ink
Agreement II-91
Bayshore Home Health Takes Over Coram Healthcare II-91
Otsuka Pharmaceutical Acquires Nardobel II-91
Glanbia Nutritionals Establishes Production Plant II-91
Nestle Establishes Infant Nutrition Facility II-92
Ventria Bioscience Increases Production of Lactoferrin II-92
Fresenius Kabi Inks Agreement with Dabur Pharma II-92
Abbott Recalls 2 Batches of Calcilo XD® Infant Formula II-92
Nutritek Divests Dairy Business to Russagroprom II-93
Hero Acquires Bledina Infant Nutrition License II-93
BioGaia and Nestle Nutrition Ink Agreement II-93

6. FOCUS ON SELECT GLOBAL PLAYERS II-94
Abbott Laboratories, Inc. (US) II-94
Abbott Nutrition (US) II-94
Ajinomoto Co., Inc. (Japan) II-94
American HomePatient, Inc. (US) II-95
Baxter International, Inc. (US) II-96
B. Braun Melsungen AG (Germany) II-97
Claris Lifesciences Ltd. (India) II-97
Groupe Danone (France) II-98
Nutricia North America (US) II-98
Fresenius Kabi AG (Germany) II-99
Hospira, Inc. (US) II-99
Mead Johnson Nutrition Company (US) II-100
List of Select Infant Nutrition Formula from Mead Johnson
Nutrition Company II-101
Meiji Co., Ltd. (Japan) II-101
Nestle Health Science S.A (Switzerland) II-102
Nestle HealthCare Nutrition (US) II-103
Otsuka Pharmaceutical Factory, Inc (Japan) II-103
Sino-Swed Pharmaceutical Corp, Ltd. (China) II-104
The H. J. Heinz Company (US) II-104

7. GLOBAL MARKET PERSPECTIVE II-105
Table 42: World Recent Past, Current and Future Analysis for
Clinical Nutrition Products by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific, Middle East/Africa and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-105

Table 43: World Historic Review for Clinical Nutrition
Products by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Middle East/Africa and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-106

Table 44: World 15-Year Perspective for Clinical Nutrition
Products by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle
East/ Africa and Latin America Markets for Years 2004, 2013
and 2018 (includes corresponding Graph/Chart) II-107

Table 45: World Recent Past, Current and Future Analysis for
Enteral Nutrition Products by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific, Middle East/Africa and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-108

Table 46: World Historic Review for Enteral Nutrition Products
by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Middle East/Africa and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-109

Table 47: World 15-Year Perspective for Enteral Nutrition
Products by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle
East/ Africa and Latin America Markets for Years 2004, 2013
and 2018 (includes corresponding Graph/Chart) II-110

Table 48: World Recent Past, Current and Future Analysis for
Infant Nutrition Products by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific, Middle East/Africa and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-111

Table 49: World Historic Review for Infant Nutrition Products
by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Middle East/Africa and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-112

Table 50: World 15-Year Perspective for Infant Nutrition
Products by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle
East/ Africa and Latin America Markets for Years 2004, 2013
and 2018 (includes corresponding Graph/Chart) II-113

Table 51: World Recent Past, Current and Future Analysis for
Parenteral Nutrition Products by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific, Middle East/Africa and
Latin America Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-114

Table 52: World Historic Review for Parenteral Nutrition
Products by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific, Middle East/ Africa and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) II-115

Table 53: World 15-Year Perspective for Parenteral Nutrition
Products by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific, Middle
East/Africa and Latin America Markets for Years 2004, 2013 and
2018 (includes corresponding Graph/Chart) II-116


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Clinical Nutrition Products Market in a Capsule III-1
Rapidly Ageing Demographics: A Major Driving Factor III-1
Table 54: North American Elderly Population by Age Group
(1975-2050) (includes corresponding Graph/Chart) III-2
Rising Incidences of Chronic Diseases Enhance Need for
Clinical Nutrition Products III-3
Cancer Statistics in the US III-3
Table 55: New Cancer Cases in the US by Gender and
Affected Site (2013) III-4
Prevalence of Diabetes Mellitus in North America III-5
Table 56: Prevalence of Diabetes Mellitus in North
America: 2012 (includes corresponding Graph/Chart) III-5

Table 57: North America Incidence of Type 1 Diabetes in
Children (2012) (includes corresponding Graph/Chart) III-6
An Insight into Infant Nutrition Market in the US III-6
Rising Number of Premature Births Augurs Well for Market
Growth III-6
Table 58: US Pre-term Birth Statistics (2012) III-7
Strategic Innovations to Buoy Consumer Demand III-8
Human Breast Milk-Like Infant Formulas to Gain Popularity III-8
A Highly Concentrated Marketplace III-9
Table 59: Leading Infant Formula (Powder) Manufacturers in
the US (2012): Percentage Share Breakdown of Value Sales
for Mead Johnson Nutrition Co, Abbott Nutrition, Nestle
Healthcare Nutrition, Gerber Products Co, Private Label
and Others (includes corresponding Graph/Chart) III-9

Table 60: Leading Infant Formula Brands in the US (2012):
Percentage Share Breakdown of Value Sales for Enfamil
Premium, Similac Advance, Similac Sensitive, Enfamil
Gentlease, Gerber Good Start Gentle Plus, Gerber Good
Start Gentle, Similac Advance Early Shield, Private label
and Others (includes corresponding Graph/Chart) III-10
WIC Contract and the Infant Formula Rebate Program III-10
WIC’s Infant Formula Rebate Program III-11
Enteral Nutrition Market III-11
Home Healthcare Fuels Demand for Home Enteral Nutrition
Products III-12
Enteral Nutrition Therapy to Treat Adult Malnutrition:
Opportunities for Growth III-12
Reimbursement Scenario for Enteral Nutrition Therapy III-13
ENT Coverage under Part A III-13
ENT Coverage under Part B III-14
Reimbursements for Enteral Nutrients III-15
Parenteral Nutrition Market: An Overview III-15
Medicare Coverage for Parenteral Nutrition Therapy III-15
Reimbursement Regulations to Hamper Market Growth III-16
Shift towards Enteral Nutrition Therapies - A Threat to the
US Parenteral Nutrition Market III-17
Advantages and Disadvantages of Enteral Nutrition over
Parenteral Nutrition III-17
A.S.P.E.N. Practice Guidelines for Parenteral Nutrition III-17
A.S.P.E.N. Guidelines for Parenteral Nutrition (as of 2004) III-18
Impact of Patient Protection and Affordable Care Act on IV
Solutions Market III-19
Product Launches III-20
Strategic Corporate Developments III-22
Key Players III-26
B.Market Analytics III-32
Table 61: US Recent Past, Current and Future Analysis for
Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-32

Table 62: US Historic Review for Clinical Nutrition Products
by Product Type - Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) III-33

Table 63: US 15-Year Perspective for Clinical Nutrition
Products by Product Type - Percentage Breakdown of Dollar
Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-34

2. CANADA III-35
A.Market Analysis III-35
Outlook III-35
Rising Incidence of Chronic Diseases: A Major Growth Driver III-35
Table 64: New Cancer Cases in Canada by Gender and Affected
Site (2012) (includes corresponding Graph/Chart) III-36

Table 65: New Cancer Cases in Canada by Province (2012)
(includes corresponding Graph/Chart) III-37

Table 66: New Cancer Cases in Canada by Age Group and
Gender (2012) (includes corresponding Graph/Chart) III-38

Table 67: Prevalence of Diabetes Mellitus in Canada (2012)
(includes corresponding Graph/Chart) III-38
An Overview of Infant Formula Market in Canada III-39
Table 68: Leading Players in the Canadian Baby Milk Market
(2012): Percentage Share Breakdown in Value Terms for
Abbott, Mead Johnson, Nestle and Others (includes
corresponding Graph/Chart) III-39
Product Launch III-40
B.Market Analytics III-41
Table 69: Canadian Recent Past, Current and Future Analysis
for Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-41

Table 70: Canadian Historic Review for Clinical Nutrition
Products by Product Type - Enteral Nutrition, Infant
Nutrition, and Parenteral Nutrition Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-42

Table 71: Canadian 15-Year Perspective for Clinical
Nutrition Products by Product Type - Percentage Breakdown of
Dollar Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-43

3. JAPAN III-44
A.Market Analysis III-44
Outlook III-44
Rising Incidence of Chronic Diseases - A Prime Growth Driver III-44
Table 72: Prevalence of Diabetes Mellitus in Japan (2012 and
2030) (includes corresponding Graph/Chart) III-45
Parenteral Nutrition Market: An Overview III-45
Key Players III-46
B.Market Analytics III-48
Table 73: Japanese Recent Past, Current and Future Analysis
for Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-48

Table 74: Japanese Historic Review for Clinical Nutrition
Products by Product Type - Enteral Nutrition, Infant
Nutrition, and Parenteral Nutrition Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-49

Table 75: Japanese 15-Year Perspective for Clinical
Nutrition Products by Product Type - Percentage Breakdown of
Dollar Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-50

4. EUROPE III-51
A.Market Analysis III-51
Outlook III-51
Debt Crisis in Europe Affects Healthcare Industry III-51
European Healthcare System: In a State of Transition? III-51
Ageing Population to Drive Demand for Clinical Nutrition
Products Market III-52
Table 76: Population Breakup by Age Group for Select
European Countries: 2012 (as a Percentage of Total
Population) (includes corresponding Graph/Chart) III-53
An Overview of Enteral Feeding Market in Europe III-53
Prospering Enteral Nutrition Market: New Avenues for
Ingredient Suppliers III-54
Surging Interest in Home Healthcare: Gains for Enteral
Nutrition Market III-54
Infant Nutrition Market III-55
Increasing Preterm Births Propel Market Growth III-55
Competitive Landscape III-55
Table 77: Leading Players in Eastern Europe Infant Formula
Market (2012): Percentage Share Breakdown of Value Sales
Groupe Danone, Nestle SA, Hipp GmbH and Co Vertrieb KG and
Others (includes corresponding Graph/Chart) III-55

Table 78: Leading Players in Western Europe Infant Formula
Market (2012): Percentage Share Breakdown of Value Sales
for Danone Groupe, Nestle SA, Lactalis Groupe and Others
(includes corresponding Graph/Chart) III-56
The EC Directive on Infant Formulae and Follow-on Formulae III-56
FSA’s Control on Infant Formulas and Follow-on Formula
Advertisements III-57
B.Market Analytics III-58
Table 79: European Recent Past, Current and Future Analysis
for Clinical Nutrition Products by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-58

Table 80: European Historic Review for Clinical Nutrition
Products by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-59

Table 81: European 15-Year Perspective for Clinical
Nutrition Products by Geographic Region - Percentage
Breakdown of Dollar Sales for France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets for Years 2004,
2013 and 2018 (includes corresponding Graph/Chart) III-60

Table 82: European Recent Past, Current and Future Analysis
for Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-61

Table 83: European Historic Review for Clinical Nutrition
Products by Product Type - Enteral Nutrition, Infant
Nutrition, and Parenteral Nutrition Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-62

Table 84: European 15-Year Perspective for Clinical
Nutrition Products by Product Type - Percentage Breakdown of
Dollar Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-63

4a. FRANCE III-64
A.Market Analysis III-64
Outlook III-64
Groupe Danone - A Key Player III-64
B.Market Analytics III-65
Table 85: French Recent Past, Current and Future Analysis
for Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-65

Table 86: French Historic Review for Clinical Nutrition
Products by Product Type - Enteral Nutrition, Infant
Nutrition, and Parenteral Nutrition Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-66

Table 87: French 15-Year Perspective for Clinical Nutrition
Products by Product Type - Percentage Breakdown of Dollar
Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-67

4b. GERMANY III-68
A.Market Analysis III-68
Outlook III-68
An Overview of the Infant Nutrition Market III-68
Strategic Corporate Developments III-68
Key Players III-69
B.Market Analytics III-71
Table 88: German Recent Past, Current and Future Analysis
for Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-71

Table 89: German Historic Review for Clinical Nutrition
Products by Product Type - Enteral Nutrition, Infant
Nutrition, and Parenteral Nutrition Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-72

Table 90: German 15-Year Perspective for Clinical Nutrition
Products by Product Type - Percentage Breakdown of Dollar
Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-73

4c. ITALY III-74
A.Market Analysis III-74
Outlook III-74
Infant Formula Market: Leading Players III-74
Table 91: Leading Players in the Italian Infant Formula
Market (2012): Percentage Share Breakdown of Value Sales
for Danone, Heinz, Nestle and Others (includes
corresponding Graph/Chart) III-74
Strategic Corporate Developments III-75
B.Market Analytics III-75
Table 92: Italian Recent Past, Current and Future Analysis
for Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-75

Table 93: Italian Historic Review for Clinical Nutrition
Products by Product Type - Enteral Nutrition, Infant
Nutrition, and Parenteral Nutrition Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-76

Table 94: Italian 15-Year Perspective for Clinical Nutrition
Products by Product Type - Percentage Breakdown of Dollar
Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-77

4d. THE UNITED KINGDOM III-78
A.Market Analysis III-78
Outlook III-78
Infant Formula Market: Competition III-78
Table 95: Leading Players in the UK Infant Formula Market
(2012): Percentage Share Breakdown of Value Sales for
Danone, Nestle and Others (includes corresponding
Graph/Chart) III-78
Vitacare - A Key Player III-79
B.Market Analytics III-79
Table 96: UK Recent Past, Current and Future Analysis for
Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-79

Table 97: UK Historic Review for Clinical Nutrition Products
by Product Type - Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) III-80

Table 98: UK 15-Year Perspective for Clinical Nutrition
Products by Product Type - Percentage Breakdown of Dollar
Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-81

4e. SPAIN III-82
A.Market Analysis III-82
Outlook III-82
Strategic Corporate Developments III-82
B.Market Analytics III-83
Table 99: Spanish Recent Past, Current and Future Analysis
for Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-83

Table 100: Spanish Historic Review for Clinical Nutrition
Products by Product Type - Enteral Nutrition, Infant
Nutrition, and Parenteral Nutrition Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-84

Table 101: Spanish 15-Year Perspective for Clinical
Nutrition Products by Product Type - Percentage Breakdown of
Dollar Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-85

4f. RUSSIA III-86
Market Analysis III-86
Table 102: Russian Recent Past, Current and Future Analysis
for Clinical Nutrition Products by Product Type - Enteral
Nutrition, Infant Nutrition, and Parenteral Nutrition
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-86

Table 103: Russian Historic Review for Clinical Nutrition
Products by Product Type - Enteral Nutrition, Infant
Nutrition, and Parenteral Nutrition Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-87

Table 104: Russian 15-Year Perspective for Clinical
Nutrition Products by Product Type - Percentage Breakdown of
Dollar Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-88

4g. REST OF EUROPE III-89
A.Market Analysis III-89
Outlook III-89
Infant Formula Market: Key Statistics III-89
Table 105: Leading Players in the Ireland Infant Formula
Market (2012): Percentage Share Breakdown of Value Sales
for Danone, Nestle SA, Heinz and Others (includes
corresponding Graph/Chart) III-89

Table 106: Leading Players in the Turkish Infant Formula
Market (2012): Percentage Share Breakdown of Value Sales
for Danone, Nestle and Others (includes corresponding
Graph/Chart) III-89
Product Launches III-90
Strategic Corporate Developments III-91
Nestle Health Science S.A (Switzerland) - A Key Player III-94
B.Market Analytics III-95
Table 107: Rest of Europe Recent Past, Current and Future
Analysis for Clinical Nutrition Products by Product Type -
Enteral Nutrition, Infant Nutrition, and Parenteral
Nutrition Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-95

Table 108: Rest of Europe Historic Review for Clinical
Nutrition Products by Product Type - Enteral Nutrition,
Infant Nutrition, and Parenteral Nutrition Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-96

Table 109: Rest of Europe 15-Year Perspective for Clinical
Nutrition Products by Product Type - Percentage Breakdown of
Dollar Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-97

5. ASIA-PACIFIC III-98
A.Market Analysis III-98
Outlook III-98
Infant Formula Market: Competition III-98
Table 110: Leading Players in the Asian Infant Formula
Market (2012): Percentage Share Breakdown of Value Sales
for Nestle SA, Groupe Danone, Mead Johnson and Others
(includes corresponding Graph/Chart) III-98
B.Market Analytics III-99
Table 111: Asia-Pacific Recent Past, Current and Future
Analysis for Clinical Nutrition Products by Geographic
Region - China, India and Rest of Asia-Pacific Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-99

Table 112: Asia-Pacific Historic Review for Clinical
Nutrition Products by Geographic Region - China, India and
Rest of Asia-Pacific Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) III-100

Table 113: Asia-Pacific 15-Year Perspective for Clinical
Nutrition Products by Geographic Region - Percentage
Breakdown of Dollar Sales for China, India and Rest of
Asia-Pacific Markets for Years 2004, 2013 and 2018 (includes
corresponding Graph/Chart) III-101

Table 114: Asia-Pacific Recent Past, Current and Future
Analysis for Clinical Nutrition Products by Product Type -
Enteral Nutrition, Infant Nutrition, and Parenteral
Nutrition Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-102

Table 115: Asia-Pacific Historic Review for Clinical
Nutrition Products by Product Type - Enteral Nutrition,
Infant Nutrition, and Parenteral Nutrition Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-103

Table 116: Asia-Pacific 15-Year Perspective for Clinical
Nutrition Products by Product Type - Percentage Breakdown of
Dollar Sales for Enteral Nutrition, Infant Nutrition, and
Parenteral Nutrition Markets for Years 2004, 2013 and 2018
(includes corresponding Graph/Chart) III-104

5a. CHINA III-105
A.Market Analysis III-105
Outlook III-105
Infant Formula Market: A Review III-105
Table 117: Infant Formula Market in China (2012):
Percentage Share Breakdown of Value Sales by Price Category
(includes corresponding Graph/Chart) III-105
Consolidation to Strengthen Infant Formula Industry III-106
China Slaps Fines on Six Infant Formula Companies for
Price-Fixing III-106
Companies Lower Prices of Infant Formula Following Anti-
Monopoly Probe III-106
Key Challenges Facing Infant Formula Market III-107
Increasing Competition from Imported Infant Nutrition Formula III-107
Birth Rate III-107
Need to Regain Consumer Confidence III-107
Others III-107
Competition in the Chinese Infant Nutrition Market III-107
Table 118: Leading Players in the Ch

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • July 2014
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2023 Summary GlobalData estimates that the total market size for the 7MM in 2013 was $12.3bn, comprised of $5.0bn in branded ...

Analysis of the Global Infectious Disease Diagnostics Market

Analysis of the Global Infectious Disease Diagnostics Market

  • $ 10 000
  • Industry report
  • September 2014
  • by Frost & Sullivan

Molecular Methods Present Significant Opportunities This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast ...

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation

  • $ 6 995
  • Industry report
  • July 2014
  • by GBI Research

Frontier Pharma: Breast Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The breast cancer pipeline is the largest in the pharmaceutical ...

Bcc Research Bitopertin Forecast

August 2014 $ 5 500

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.